Impurities, degradants and metabolites of active pharmaceutical and excipients. Isolation, purification and characterisation of high purity compounds and complex molecules. Milligram to multigram scale Analysis to your requirements including NMR, LCMS, GCMS, HPLC, IR and water content. Isolation & Structure Elucidation Of Unknown Impurities Pharmaceutical Reference Standards Contract Research Services Development of new synthetic routes Delivering custom synthesis at off the shelf pricing Process research, development and optimization Cost-effective and high efficiency

Provides high-quality intermediates essential for active pharmaceutical ingredient (API) development. Supplies process-related, degradation, and potential impurities for regulatory submissions. Ensures compliance with global pharmacopeial standards and GMP practices.

Offers diverse chemical scaffolds and reactive intermediates used in drug discovery and chemical development. Enables rapid structure-activity relationship (SAR) studies through ready-to-use compounds. Customized to meet medicinal chemistry and high-throughput screening demands.

Synthesizes drug metabolites for use in preclinical and clinical pharmacokinetic or toxicology studies. Supports both major and minor metabolite production under stringent analytical controls. Facilitates regulatory submissions by providing metabolite reference materials.

Designs and delivers lead-like molecules to support early-stage medicinal chemistry programs. Supports hit-to-lead and lead optimization with analog synthesis. Backed by SAR-driven synthesis and rapid iteration cycles.

Provides isotopically labeled deuterated compounds for use in ADME studies and drug stability enhancement. Improves pharmacokinetics, metabolic resistance, and intellectual property protection. Supports synthesis of custom deuterium-substituted analogs on demand.

Synthesizes compound libraries targeting specific protein families, pathways, or therapeutic areas. Supports high-throughput screening with structurally diverse yet focused molecules. Accelerates hit identification and early-stage lead discovery.

Develops efficient synthetic routes for new chemical entities with scalable and cost-effective processes. Optimizes yield, purity, and safety through route selection, risk assessment, and condition refinement. Supports lab-to-pilot scale transition for production readiness.